Materials Healthcare Sector

PreveCeutical Medical

Market Cap: CA$17.0m

A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

BioRestorative Therapies

Market Cap: US$12.1m

Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.

Marker Therapeutics

Market Cap: US$11.9m

A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.

Induction Healthcare Group

Market Cap: UK£8.9m

Provides software to healthcare professionals in the United Kingdom.

Precipio

Market Cap: US$11.9m

A healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States.

Welsis

Market Cap: US$11.8m

A development stage startup company, engages in the provision of online psychological help services.

OncoSil Medical

Market Cap: AU$18.4m

A medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in Australia, New Zealand, and Europe.

Abpro Holdings

Market Cap: US$11.8m

A biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology.

DiagnosTear Technologies

Market Cap: CA$16.5m

An ophthalmic company, engages in developing and commercializing disruptive diagnostic solutions for eye diseases.

Red White & Bloom Brands

Market Cap: CA$16.5m

Manufactures, processes, and distributes cannabis products and accessories in the United States and Canada.

Scienture Holdings

Market Cap: US$11.7m

Operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States.

IN8bio

Market Cap: US$11.7m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.

Cosmos Health

Market Cap: US$11.7m

Manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus.

Numinus Wellness

Market Cap: CA$16.1m

Provides psychedelic-assisted psychotherapy products and services in Canada and the United States.

Aesthetic Medical International Holdings Group

Market Cap: US$11.5m

Provides aesthetic medical services in the People’s Republic of China and Singapore.

Bionano Genomics

Market Cap: US$11.4m

Provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.

IXICO

Market Cap: UK£8.6m

Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.

NuGen Medical Devices

Market Cap: CA$15.9m

A specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally.

Hoth Therapeutics

Market Cap: US$11.3m

A clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs.

Emyria

Market Cap: AU$17.7m

Engages in delivering and developing of new treatments for unmet needs in mental health and select neurological conditions in Australia.

Sirona Biochem

Market Cap: CA$15.8m

A cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France.

Cellectar Biosciences

Market Cap: US$11.3m

A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.

genedrive

Market Cap: UK£8.5m

Engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications.

Bolt Biotherapeutics

Market Cap: US$11.2m

A clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer.

COSCIENS Biopharma

Market Cap: CA$15.7m

A life science company, engages in developing and commercializing products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Columbia, the United Kingdom, and internationally.

Bright Green

Market Cap: US$11.2m

Produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States.

Curative Biotechnology

Market Cap: US$11.2m

A development-stage biomedical company, develops, licenses, and commercializes pharmaceutical products and medical devices.

Cell Source

Market Cap: US$11.2m

A biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance.

ImExHS

Market Cap: AU$17.4m

Offers cloud-based medical imaging solutions in Australia and internationally.

Bioxytran

Market Cap: US$11.1m

A clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans.

Rhythm Biosciences

Market Cap: AU$17.3m

A medical diagnostics company, provides blood tests for the detection of cancers in Australia.

STRATA Skin Sciences

Market Cap: US$11.1m

A medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.

Evaxion

Market Cap: US$11.0m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

Promisia Healthcare

Market Cap: NZ$18.7m

Engages in the aged care and retirement living business in New Zealand.

CS Diagnostics

Market Cap: US$11.0m

Manufactures and sells medical products for medicine, radiology, cardiology, and radiation therapy in Germany and internationally.

LexaGene Holdings

Market Cap: CA$14.8m

LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems.